ArticleUnited European gastroenterology journal2024
Reasons why treatment of metabolic dysfunction-associated steatotic liver disease may benefit from targeting the gut-liver axis as well.
Claudia Mandato et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.